Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Moiola

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
Journal of the Neurological Sciences|January 26, 2024
Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' managementChiara Zanetta, Patricia Faustino, Simone Guerrieri, et al.
BMC Neurology|September 27, 2015
Natalizumab in the pediatric MS population: results of the Italian registryAngelo Ghezzi, Lucia Moiola, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2020
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosisLaura Ferrè, Andrea Mogavero, Ferdinando Clarelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Practice of yoga may cause damage of both sciatic nerves: a case reportPatrizia Dacci, Stefano Amadio, Simonetta Gerevini, et al.
Journal of Neurology|February 2, 2026
Substrates of 8.5-year clinical outcomes in aquaporin-4 IgG-positive neuromyelitis optica spectrum disordersMonica Margoni, Mor Gueye, Alessandro Meani, et al.
Journal of Neurology|May 23, 2026
Cerebrovascular risk factors impact on brain atrophy and DTI-ALPS decrease in neuromyelitis optica spectrum disorderMartina Rubin, Paolo Preziosa, Monica Margoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2010
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosisFederica Esposito, Marta Radaelli, Vittorio Martinelli, et al.
CNS Drugs|November 25, 2016
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis ExpertsThomas Berger, Irina Elovaara, Sten Fredrikson, et al.
Annals of Neurology|January 18, 2025
Subventricular Zone Microstructure in Pediatric-Onset Multiple SclerosisMonica Margoni, Loredana Storelli, Elisabetta Pagani, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patientsFrancesca Sangalli, Lucia Moiola, Laura Ferrè, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Journal of the Neurological Sciences|January 26, 2024
Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' managementChiara Zanetta, Patricia Faustino, Simone Guerrieri, et al.
BMC Neurology|September 27, 2015
Natalizumab in the pediatric MS population: results of the Italian registryAngelo Ghezzi, Lucia Moiola, Carlo Pozzilli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2020
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosisLaura Ferrè, Andrea Mogavero, Ferdinando Clarelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Practice of yoga may cause damage of both sciatic nerves: a case reportPatrizia Dacci, Stefano Amadio, Simonetta Gerevini, et al.
Journal of Neurology|February 2, 2026
Substrates of 8.5-year clinical outcomes in aquaporin-4 IgG-positive neuromyelitis optica spectrum disordersMonica Margoni, Mor Gueye, Alessandro Meani, et al.
Journal of Neurology|May 23, 2026
Cerebrovascular risk factors impact on brain atrophy and DTI-ALPS decrease in neuromyelitis optica spectrum disorderMartina Rubin, Paolo Preziosa, Monica Margoni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2010
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosisFederica Esposito, Marta Radaelli, Vittorio Martinelli, et al.
CNS Drugs|November 25, 2016
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis ExpertsThomas Berger, Irina Elovaara, Sten Fredrikson, et al.
Annals of Neurology|January 18, 2025
Subventricular Zone Microstructure in Pediatric-Onset Multiple SclerosisMonica Margoni, Loredana Storelli, Elisabetta Pagani, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patientsFrancesca Sangalli, Lucia Moiola, Laura Ferrè, et al.
Pageof 16